Enoxacin sesquihydrate
- Level
- Commodity
- Parent
- 51282900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51282954This classification denotes an anti-infective agent 2C15H17FN4O3.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I9CD31N8WB, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrate (2:3), but more generally known as enoxacin sesquihydrate, which bears US NIH Compound Identifier 3229. European Medicines Agency schedules SUB13675MIGin its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13675MIG. Most nations schedule enoxacin sesquihydrate under HS 29335995 and SITC 51576. As of Q4 2014, ENOXACIN SESQUIHYDRATE remains the US FDA Preferred Term for this commodity. SMILES: CCN1CC(C(=O)C2C1NC(C(C2)F)N3CCNCC3)C(=O)O.CCN1CC(C(=O)C2C1NC(C(C2)F)N3CCNCC3)C(=O)O.O.O.O.
Same parent
Under 51282900 · 57Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.